GSK's Ebola Vaccine Shows Promise In First Trial
A report published Wednesday on a trial for an experimental GlaxoSmithKline PLC vaccine for the Ebola virus said that it was safe and provoked an immune response in subjects, offering hope...To view the full article, register now.
Already a subscriber? Click here to view full article